Key facts
- Notable investors include MicroVentures, Seeds of Bravery.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for biodrook
- ·The full record, as it builds
Funding rounds
No funding rounds for biodrook are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About biodrook
Developer of end-to-end 3D-printed bone implant technology designed to advance surgical recovery and regenerative medicine. The company features a seamless platform for 3D modeling from MRI/CT scans, proprietary in-house manufacturing, and certified, ready-to-implant sterile products, enabling surgeons and medical institutions to deliver personalized bone implants, offering improved patient outcomes, streamlined surgical workflows, and access to cutting-edge regenerative tools.
- Sector
- Healthcare
- HQ
- Bila Tserkva, Ukraine
- Founded
- 2024
- Employees
- 12
- Website
- biodrook.com/
- Ownership
- Privately Held (backing)
biodrook doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in biodrook shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on biodrook in its N-PORT filings yet. We sweep new filings monthly.